Jazz Pharmaceuticals Adds 2% on Q4 Earnings Results

Jazz Pharmaceuticals JAZZ released its Q4 earnings results after the closing bell on Monday. The company reported EPS of $1.17, which compared to analysts' consensus estimates of $1.09. Revenues for the quarter were $83.5 million versus consensus estimates of $80.84 million. In Monday's after hours trading session, JAZZ shares are trading up a little better than 2% to $51.70.